Inhibikase Therapeutics, Inc.(IKT)
盘后1.650.000.00%16:10 EST
1.65-0.05-2.94%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称Inhibikase Therapeutics, Inc.所属市场NASDAQ成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况Inhibikase Therapeutics, Inc.于2010年6月3日注册为特拉华州公司。该公司是一家临床阶段制药公司，致力于开发针对帕金森氏病或PD以及大脑内外发生的相关疾病的疗法。- 2025-12-19Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-11-21Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-11-20Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-11-14Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-11-14Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-08-14Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-08-14Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-06-30Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-06-26Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 2025-05-14Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-05-14Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-04-25Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend][修订]年度报告Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
- 2025-04-14Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-03-27Form S-8 - Securities to be offered to employees in employee benefit plans员工持股计划Form S-8 - Securities to be offered to employees in employee benefit plans
- 2025-03-27Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]年度报告Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
1.70
今开
1.70
量比
0.64
最低
1.64
昨收
1.70
换手率
0.43%